AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,000 | -64.7% | 7,428 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | -19.0% | 7,428 | 0.0% | 0.00% | – |
Q3 2021 | $21,000 | -25.0% | 7,428 | 0.0% | 0.00% | – |
Q2 2021 | $28,000 | +12.0% | 7,428 | 0.0% | 0.00% | – |
Q1 2021 | $25,000 | +19.0% | 7,428 | 0.0% | 0.00% | – |
Q4 2020 | $21,000 | +10.5% | 7,428 | 0.0% | 0.00% | – |
Q3 2020 | $19,000 | -81.0% | 7,428 | 0.0% | 0.00% | – |
Q2 2020 | $100,000 | +194.1% | 7,428 | +66.3% | 0.00% | – |
Q1 2020 | $34,000 | +21.4% | 4,466 | 0.0% | 0.00% | – |
Q4 2019 | $28,000 | -31.7% | 4,466 | -46.9% | 0.00% | – |
Q2 2019 | $41,000 | -40.6% | 8,418 | 0.0% | 0.00% | – |
Q1 2019 | $69,000 | +53.3% | 8,418 | 0.0% | 0.00% | – |
Q4 2018 | $45,000 | +9.8% | 8,418 | +80.1% | 0.00% | – |
Q3 2018 | $41,000 | -12.8% | 4,675 | 0.0% | 0.00% | – |
Q2 2018 | $47,000 | +4.4% | 4,675 | 0.0% | 0.00% | – |
Q1 2018 | $45,000 | -34.8% | 4,675 | 0.0% | 0.00% | – |
Q4 2017 | $69,000 | – | 4,675 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
Ergoteles LLC | 849,000 | $300,000 | 0.01% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |